Background: Effective new anti-human cytomegalovirus (HCMV) agents and regimens need to be developed. We examined the anti-HCMV properties of crude extract (True World Extract of Bambuseae sasa [TWEBS]) and five compounds (p-coumaric acid, 3-hydroxy-4-methoxybenzaldehyde [vanillin]
, p-hydroxybenzaldehyde, 3-hydroxypyridine and 4′,5,7-trihydroxy-3′,5′-dimethoxyflavone [tricin]), isolated from Sasa albo-marginata, a bamboo known in Japan as Sasa. Methods: Among TWEBS and five compounds screened in a plaque reduction assay, four showed anti-HCMV activity in the MRC-5 human embryonic fibroblast cell line. The anti-HCMV mechanisms of the TWEBS was examined by western blot analysis using primary antibody specific for an immediate early (IE) antigen of HCMV, for a structural late antigen of HCMV and for β-actin.
Results: Treatment of cells with ≥0.001% of TWEBS inhibited the observable cytopathic effects of HCMV on infected cells. Western blot analysis demonstrated that TWEBS decreased the expression of IE antigen and late
antigen of HCMV in the infected cells. Next, we examined the anti-HCMV properties of five compounds isolated from TWEBS. In a viral plaque reduction assay, tricin showed dose-dependent inhibitory properties with a 50% effective concentration of 0.17 µg/ml (selective index =1,205.8). Conclusions: The hot water extract (TWEBS) of Sasa albo-marginata, with tricin isolated from it, has anti-HCMV activity in MRC-5 cells. TWEBS and/or tricin are a novel compound with potential anti-HCMV activity. Future studies should evaluate these findings in vivo.
Human cytomegalovirus (HCMV) is one of eight herpesviruses known to infect humans. It is a widespread human pathogen that has a minor clinical effect on healthy individuals, but causes various organ diseases in immunosuppressed patients and neural damage in fetuses infected in utero [1] . HCMV persists as a lifelong latent infection. However, HCMV is frequently activated in immunocompromised individuals, such as patients with AIDS or organ transplants, thereby causing severe morbidity and eventual mortality [2] [3] [4] [5] . Symptomatic HCMV infection has been treated successfully with ganciclovir (GCV), but the appearance of GCV-resistant viruses is a recurrent problem in the treatment of immunocompromised patients with HCMV infection. Although foscarnet and cidofovir have been used in combination with GCV for the treatment of GCV-resistant HCMV, these treatments are not always successful [6] . Therefore, effective new anti-HCMV agents and regimens need to be developed [7] [8] [9] [10] .
Plants are important sources of biologically active natural products, that differ widely in terms of structure and biological properties. The bamboo genus Sasa is a member of the family Gramineae, which are distributed throughout Japan, the Russian part of the Kuril Islands and the southern part of Sakhalin Island. Extracts of Sasa have been used as a traditional medicine and as wrapping material for foods throughout Asia. Sasa albo-marginata is well-known as Kumazasa in Japan. The water-soluble fraction of this plant has a number of biological activities, including anti-ulcerogenic and anti-inflammatory properties [11] [12] [13] [14] [15] . However, there have not been reports concerning antiviral properties of Sasa albo-marginata. With the development of drug resistance a constant Introduction concern, the search for new antiviral agents from a variety of sources, including plants, has assumed more urgency than in the past [16] . In the present study, we show that the hot water-soluble fraction of Sasa albo-marginata and five compounds isolated from it have anti-HCMV properties in the human embryonic fibroblast cell line MRC-5.
Methods

Cell and viruses
The human embryonic lung fibroblast cell line, MRC-5 [17] was grown in Dulbecco's modified Eagle's minimal essential medium (DMEM; Nissui Pharmaceutical Co., Ltd., Tokyo, Japan) supplemented with 10% heat-inactivated fetal calf serum (FCS; Bocknek Ltd., Rexdale, ON, Canada), l-glutamine (0.3 mg/ml; Nacarai Tesque Inc., Kyoto, Japan), streptomycin (100 µg/ ml; Nacarai Tesque Inc.) and penicillin (100 units/ml; Nacarai Tesque Inc.). All cell cultures were maintained in a humidified incubator at 37°C in the presence of 5% carbon dioxide.
The laboratory-adapted HCMV Towne strain was used as a standard strain throughout the experiment [18] . Both GCV-resistant and GCV-sensitive HCMV strains were isolated from a patient with HCMV retinitis/encephalitis [19] . The strains were plaque-purified twice and propagated in human embryonic lung (HEL) fibroblasts and designated 93-1R and 91-7S, respectively [20] . These HCMVs were propagated in HEL cells. The viral infectivity was determined by a plaque assay [21] . Confluent MRC-5 cells in 24-well plates (Falcon #3047, Becton Dickinson, Franklin Lakes, NJ, USA) were infected with HCMV. After virus adsorption at 37°C for 1 h, each inoculum was removed, and the monolayer was overlaid with 2 ml of DMEM containing 2% FCS and 0.6% agar and incubated at 37°C. After 7 days of culture, the cells were fixed with formaldehyde and stained with crystal violet, and the numbers of plaques were counted microscopically.
Plant materials
The hot water extract (True World Extract of Bambuseae sasa [TWEBS]) of the dried leaves of Sasa albo-marginata (provided by Hououdou Co. Ltd., Tokyo, Japan) was used. In total, 50 kg of dried leaves was combined with 1,000 l of water and extracted at 170°C over a period of 3 h. The extracted solution was filtered. The major components in 100 g of extracted solution were protein (10.7 g), lipid (0.7 g), carbohydrate (24.3 g), sodium (1.2 g), ash (11.2 g), calcium (0.008 g), potassium (4.7 g), iron (0.004 g), lignin (12.1 g), xylose (6.1 g), galactose (1.3 g), arabinose (1.0 g), mannose (0.12 g), ribose (0.16 g), vitamin B2 (1.4 mg), vitamin B6 (0.7 mg) and niacin (10.2 mg). This extract's chemical composition was obtained by HPLC analysis.
Isolation of the compounds
The hot water extract of Sasa albo-marginata was partitioned successively with ethyl acetate and n-butanol. The ethyl acetate fraction (52.0 g) was fractionated using a silica gel 60 (Cica-reagent, 40-50 µm) column (inner diameter 6×50 cm, 500 g) and eluted in turn with n-hexane-ethyl acetate and methanol. This process yielded seven fractions (A to G). Fraction C (3.16 g) was separated into two phases, a solid phase and a liquid phase. Recrystallization of the solid phase with CHCl 3 -acetone yielded pure compound [1] (478 mg). The liquid phase (2.20 g) was applied to a silica gel column (Cica-reagent, 100 g) and eluted with 
3-Hydroxy-4-methoxybenzaldehyde (vanillin) [2]
Mp: 114-115°C. IR (KBr): 3179, 1668 cm -1 . 1 
Susceptibility test
When MRC-5 cells in 24-well plates reached confluence, the cells were inoculated with HCMV at a multiplicity of infection (MOI) of 0.1. After adsorption for 1 h, cells were incubated in 1 ml of DMEM containing 2% FCS with or without Sasa albo-marginata plant extracts for 3 or 6 days after HCMV infection. Infectious virus production was titrated using a plaque assay [21] . In brief, confluent MRC-5 cells in 24-well plates were infected with HCMV. After virus adsorption at 37°C for 1 h, each inoculum was removed, and the monolayer was overlaid with 2 ml of DMEM containing 2% FCS and 0.6% agar and incubated at 37°C. After 7 days of culture, the cells were fixed with 10% formaldehyde at room temperature for 30 min and stained with 0.03% crystal violet at room temperature for 60 min, and the numbers of plaques were counted microscopically. The plaque reduction rate was calculated based on the mean plaque number in the control cells incubated without compounds of extracts. The 50% effective concentration (EC 50 ) for viral replication (antiviral activity) was determined from a dose-response curve constructed with triplicate samples. The 50% inhibitory concentration (IC 50 ) value for viable cell number (as a measure of cytotoxicity to MRC-5 cells) was determined from a dose-response curve constructed with triplicate samples using a trypan blue dye exclusion test.
Western blot analysis
Proteins from HCMV-infected cells were separated by SDS-PAGE on a 10% gel. Proteins were then transferred to a PVDF membrane (Hybond-p, Amersham Pharmacia Biotech AB, Uppsala, Sweden) according to the manufacturer's instructions using 20 mM Tris, 150 mM glycine, pH 8.3 in 20% methanol as the blotting buffer. Membranes were incubated for 1 h at room temperature with the blocking reagent (5% skim milk, Tris-buffered saline 0.5% Tween 20 pH 7.6 [TBS-T]), followed by 1 h at room temperature with primary antibody (mouse monoclonal antibody: MAB810, specific for an immediate early [IE1 and IE2] antigen of HCMV [Millipore, Billerica, MA, USA]; 0896, specific for a structural late protein of HCMV [ViroStat, Portland, ME, USA]; or C4, specific for β-actin [Chemicon International Inc., Temecula, CA, USA]) diluted 1:2,000 in TBS-T. A β-actin was used to monitor the levels of actin as an internal control for protein induction. The membranes were washed three times in TBS-T and incubated with peroxidase-conjugated second antibody diluted 1:10,000 in TBS-T for 1 h at room temperature. After washing three times in TBS-T, immune complexes were detected by the ECL TM system (Amersham Biosciences, Pittsburgh PA, USA) according to the manufacturer's instructions.
Statistical analyses
Data were analysed using Student's t-test.
Results
TWEBS decreased HCMV replication
The effects of TWEBS on HCMV replication in MRC-5 cell cultures were analysed. Figure 2 shows a typical experiment to determine the HCMV replication in either untreated or TWEBS-treated cultures. MRC-5 cells were infected with HCMV produced infectious HCMV at 6 days post-infection (dpi) or later. We observed a significant decrease in viral replication in cells treated with TWEBS (P<0.05). Next, to examine the dose-dependent effect of TWEBS on HCMV replication, we determined the replication of HCMV in MRC-5 cells treated with TWEBS at various concentrations. An inhibitory effect on HCMV replication was observed in cells treated with at least 0.001% of TWEBS (Figure 2A ). The virucidal effects of TWEBS were then examined after incubation of cell-free HCMV with concentrations of 0.001-1% TWEBS. The infectivity of cell-free HCMV was unchanged ( Figure 2B ).
Inhibition of cytopathic effects on HCMV-infected MRC-5 cells by TWEBS
HCMV inoculated onto monolayered MRC-5 cells (MOI of 1 plaque-forming unit per cell) was allowed to adsorb for 1 h at 37°C. The cultures were then washed twice and incubated with or without TWEBS (0.001-0.1%). At 3 dpi (Figure 3 ) cells were observed through a microscope. We documented the reduction of cytopathic effect (CPE) as any decrease in the occurrence of round cells as a result of incubation with TWEBS ( Figures 3D, 3E & 3F) . Round cells will appear both on aging cells of culture and CPE. However, it is difficult to differentiate the round cells from aging and atypical CPE. Therefore, any method for detecting HCMV antigens on cell culture instead of CPE is much more acceptable. Many cells showed CPE without TWEBS ( Figure 3C ). There was very little rounding in most of the cells treated only with TWEBS and in the cells not infected with HCMV ( Figure 3B ).
Effect of TWEBS on HCMV protein synthesis
To determine the molecular nature of IE and late proteins expressed in the TWEBS-treated cells (0.01%), we examined their synthesis in MRC-5 cells at the indicated time intervals by western blot analysis. As shown in Figure 4 , HCMV IE and late proteins were synthesized in HCMVinfected, TWEBS-untreated cells at every time interval tested. In contrast, IE protein synthesis (especially IE2) was reduced by treatment of the HCMV-infected cells with TWEBS at 1 dpi (Figure 4, lane 3) . Moreover, the late antigen synthesis was also strongly inhibited by TWEBS treatment (Figure 4, lanes 5 and 7) .
Effect of compounds on HCMV replication
When the inhibitory effects of the compounds on HCMV replication in MRC-5 cells were examined at 6 dpi, tricin was found to be the most effective among the five compounds ( Figure 5A ). The anti-HCMV activity of tricin was compared with that of GCV against the HCMV Towne strain. After adsorption for 1 h, the cells were incubated in the presence of various concentrations of either tricin or GCV and cultured for 6 days. Tricin and GCV inhibited the replication of the Towne strain at concentrations ranging from 0.13-11.1 µg/ ml and 0.03-2.6 µg/ml, respectively (P<0.05; Figure  5B ). The EC 50 of tricin for HCMV production was 0.17 µg/ml ( Table 1 ). The IC 50 of tricin for MRC-5 cells was 205.0 µg/ml. Therefore, the selectivity index of tricin, based on the ratio of IC to EC, was 1,205.8 (205.0/0.17). Moreover, the EC 50 , IC 50 , and selectivity index of TWEBS were 0.00068%, 0.29% and 426.5%, respectively (data not shown).
Discussion
We have demonstrated the effect of TWEBS on the replication of HCMV in MRC-5 cells. This hot water extract (TWEBS) of Sasa albo-marginata was first studied for anti-HCMV activity in MRC-5 cells and an inhibitory effect was observed at a concentration of 0.001%. The EC 50 of TWEBS for HCMV production was 0.00068% (data not shown). These anti-HCMV properties were demonstrated further through plaque and gene expression assays. Shibata et al. [13, 14] reported that hot water extracts of some Sasa plants have been found to have anti-inflammatory and antiulcerogenic activities in vivo. Although the inhibitory effect on host cell growth reduces the production of HCMV, TWEBS did not inhibit the growth of MRC-5 cells at concentrations of ≤0.1%, at which concentration there was no decrease in the number of MRC-5 cells observed after incubation in the presence of TWEBS compared with those incubated in the absence of TWEBS. Furthermore, in spite of the profound inhibition of viral replication, the percentage of viable cells IE protein expression following TWEBS treatment was investigated and the results showed that TWEBS inhibited IE (especially IE2) synthesis in the viral replication cycle, suggesting that TWEBS might inhibit IE gene expression after entry of HCMV. TWEBS did not inhibit the entry of HCMV to the host cells (data not shown). Recently, we demonstrated similar effects with pristimerin isolated from Maytenus heterophylla, a Kenyan medicinal plant that inhibits HCMV replication via inhibition of IE2 gene expression [22] . The inhibitory effect of TWEBS on HCMV replication could be attributed to the reduction of IE protein synthesis because the IE proteins play an important role in HCMV pathogenesis [23, 24] . As strong transactivators, the IE proteins stimulate the transcription of host cellular genes involved in cell cycle regulation, inflammatory immune responses and others [23, [25] [26] [27] [28] . In our previous reports, we demonstrated that IE gene expression might be sufficient to activate AP-1 and NF-kB, resulting in interleukin-8 gene expression [23, 29] . Considering the results of this study, the inhibitory effect of TWEBS on IE proteins might interact with this process. Viral DNA inhibition by TWEBS was probably due to an indirect consequence of reduced IE gene expression [30, 31] .
Furthermore, we examined the inhibitory effects of five compounds extracted from Sasa albo-marginata on the replication of HCMV in MRC-5 cells. Tricin exhibited distinct anti-HCMV properties, with an EC 50 of 0.17 µg/ml. Zhen et al. [32] reported that GCV also effectively inhibited HCMV plaque formation with an IC 50 value of 1.03 µg/ml. Tricin was first examined for its inhibitory effect on HCMV replication in MRC-5 cells. Its anti-HCMV activity was demonstrated further through plaque and gene expression assays, as was done with TWEBS (data not shown). This low concentration is sufficient to inhibit HCMV replication in vitro. Although the inhibitory effect on the growth of the host cells might reduce the production of HCMV virions, tricin did not inhibit the growth of MRC-5 cells, that is, no decrease in the number of cells was observed in MRC-5 cells incubated for 6 days in the presence of tricin compared with controls (data not shown). Moreover, we have preliminary data that tricin inhibits the expression of IE protein. The mechanism of part of anti-HCMV activity of tricin might be similar with TWEBS. Therefore, we think that tricin is a major component of TWEBS for anti-HCMV activity. It is of interest that in spite of the substantial inhibition of viral replication and degree of CPE, the percentage of viable cells in the presence of tricin was unaltered when compared with untreated control cultures. It is known that tricin exhibits antiviral, antioxidant, antitumor and anti-inflammatory properties [33] [34] [35] [36] [37] . Some herbal medicines are useful in the treatment of AIDS patients in whom opportunistic HCMV infection is very common and also tends to become severe. Therefore, TWEBS and/or tricin compounds extracted from Sasa albo-marginata might be candidates for natural anti-HCMV compounds and useful as cotherapeutic agents against HCMV in immunocompromised hosts. Further investigations of reaction mechanisms, chemical modification of tricin and in vivo efficacy studies should be conducted to further develop these compounds for clinical use. Table 1 . Comparison of anti-HCMV activity of five compounds extracted from Sasa albo-marginata MRC-5 cells were infected with human cytomegalovirus (HCMV) and incubated with Sasa albo-marginata plant isolates. The virus titres in the culture supernatants were determined on day 6 after HCMV infection using a plaque reduction assay. EC 50 , 50% effective concentration; IC 50 , 50% inhibitory concentration (cytotoxicity); SI, selectivity index.
